Early feasibility study for Velocity pAVF system now fully enrolled
Venova Medical has announced the completion of patient enrolment in the company's VENOS-2 early feasibility study of the Velocity percutaneous arteriovenous fistula (pAVF) system...
WAVE trial update reports sustained 12-month survival benefit
Twelve-month results from the WRAPSODY Arteriovenous Access Efficacy (WAVE) pivotal trial show a statistically significant improvement in target lesion primary patency (TLPP) with the...
Xeltis set to secure €10 million from European Innovation Council
Xeltis has successfully passed the evaluation phase of the 2025 European Innovation Council (EIC) STEP Scale-Up call programme, and is set to secure a...
Diality adds Chris Spring to board of directors
Diality, a medical device company that has developed the Moda-flx haemodialysis system, has announced the addition of Chris Springer to its board of directors.
Springer...
